Work

Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease

Year: 2022

Type: article

Source: Clinical Gastroenterology and Hepatology

DOI: 10.1016/j.cgh.2022.10.037

Authors: Konstantinos Papamichael, Niels Vande Casteele, Bincy P. Abraham, Timothy Ritter, Anjali Jain, Adam S. Cheifetz

Institutions: Beth Israel Deaconess Medical Center, University of California San Diego, Houston Methodist, Prometheus Biosciences (United States)

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4308786222

FWCI: 1.055

Cites: 14

Cited by: 9

Related to: 10